Podcasts about Jayaraman

In this episode of FinTech Impact, host Jason Pereira interviews Rajesh Jayaraman, founder and CEO of Flextract. Flextract is an innovative onboarding tool designed to help financial advisors streamline the client onboarding process by leveraging AI-powered data extraction. Rajesh discusses the origins of the company, the technology behind their product, and how it enhances both advisor efficiency and client experience. They delve into the challenges of managing disparate client data and the future roadmap for Flextract, including dynamic checklists and advanced report generation. This episode is a must-listen for anyone interested in the future of financial technology and client management. Hosted on Acast. See acast.com/privacy for more information.

Dystrophinopathies are heritable muscle disorders caused by pathogenic variants in the DMD gene, leading to progressive muscle breakdown, proximal weakness, cardiomyopathy, and respiratory failure. Diagnosis and management are evolving areas of neuromuscular neurology. In this episode, Kait Nevel, MD, speaks with Divya Jayaraman, MD, PhD, an author of the article "Dystrophinopathies" in the Continuum® October 2025 Muscle and Neuromuscular Junction Disorders issue. Dr. Nevel is a Continuum® Audio interviewer and a neurologist and neuro-oncologist at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Jayaraman is an assistant professor of neurology and pediatrics in the division of child neurology at the Columbia University Irving Medical Center in New York, New York. Additional Resources Read the article: Dystrophinopathies Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @IUneurodocmom Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Nevel: Hello, this is Dr Kate Nevel. Today I'm interviewing Dr Divya Jayaraman about her article on dystrophinopathies, which she wrote with Dr Partha Ghosh. This article appears in the October 2025 Continuum issue on muscle and neuromuscular junction disorders. Divya, welcome to the podcast, and please introduce yourself to the audience. Dr Jayaraman: Thank you so much, Dr Nevel. My name is Divya, and I am an assistant professor of Neurology and Pediatrics at Columbia University Irving Medical Center, and also an attending physician in the Pediatric Neuromuscular program there. In that capacity, I see patients with pediatric neuromuscular disorders and also some general pediatric neurology patients and also do research, primarily clinical research and clinical trials on pediatric neuromuscular disorders. Dr Nevel: Wonderful. Thank you for sharing that background with us. To set us on the same page for our discussion, before we get into some more details of the article, perhaps, could you start with some definitions? What comprises the dystrophinopathies? What are some of the core features? Dr Jayaraman: So, the dystrophinopathies, I like that term because it is a smaller subset from the muscular dystrophies. The dystrophinopathies are a spectrum of clinical phenotypes that are all associated with mutations in the DMD gene on chromosome X. So, that includes DMD---or, Duchenne muscular dystrophy---, Becker muscular dystrophy, intermediate muscular dystrophy (which falls in between the two), dilated cardiomyopathy, asymptomatic hyperCKemia, and manifesting female carriers. In terms of the core features of these conditions, so, there's some variability, weakness being prominent in Duchenne and also Becker. The asymptomatic hyperCKemia, on the other hand, may have minimal symptoms and might be found incidentally by just having a high CK on their labs. They all will have some degree of elevated CK. The dilated cardiomyopathy patients, and also the Becker patients to a lesser degree, will have cardiac involvement out of proportion to skeletal muscle involvement, and then the manifesting carriers likewise can have elevated CK and prominent cardiac involvement as well as some milder weakness. Dr Nevel: Now that we have some definitions, for the practicing neurologists out there, what do you think is the most important takeaway from your article about the dystrophinopathies? Dr Jayaraman: I like this question because it suggests that there's something that, really, any neurologist could do to help us pick up these patients sooner. And the big takeaway I want everyone to get from this is to check the CK, or creatine kinase, level. It's a simple, cheap, easy test that anyone can order, and it really helps us a lot in terms of setting the patient on the diagnostic odyssey. And in terms of whom you should be thinking about checking a CK in, obviously patients who present with some of the classic clinical features of Duchenne muscular dystrophy. This would include young boys who have toe walking, as they're presenting, sign; or motor delayed, delayed walking. They may have calf hypertrophy, which is what we say nowadays. You might have seen calf pseudohypertrophy in your neurology textbooks, but we just say calf hypertrophy now. Or patients can often have a Gowers sign or Gowers maneuver, which is named after a person called Gowers who described this phenomenon where the child will basically turn over and use their hands on the floor to stand up, usually with a wide-based gait, and then they'll sort of march their hands up their legs. That's the sort of classic Gowers maneuver. There are modified versions of that as well. So, if anyone presents with this classic presentation, for sure the best first step is to check a CK. But I would also think about checking a CK for some atypical cases. For example, any boy with any kind of motor or speech delay for whom you might not necessarily be thinking about a muscle disorder, it's always good practice to check a CK. Even a boy with autism for whom you may not get a good clinical exam. This patient might present to a general pediatric neurology clinic. I always check a CK in those patients, and you'll pick up a lot of cases that way. For the adult folks in particular, the adult neurologist, a female patient could show up in your clinic with asymptomatic hyperCKemia. And I think it's an important differential to think about for them because this could have implications not just for their own cardiac risks, but also for their family planning. Dr Nevel: So, tell us a little bit more about the timing of diagnosis. Biggest takeaway: check a CK if this is anywhere on your radar, even if somewhat of an atypical case. Why is it so important to get kiddos started on that diagnostic odyssey, as you called it, early? Dr Jayaraman: This is especially important for kids because if they especially get a Duchenne muscular dystrophy diagnosis, you might be making them eligible for treatments that we've had for some time, and also treatments that were not available earlier that hinge on making that diagnosis. So, for example, people may be skeptical about steroids, but there's population data to suggest that initiation and implementation of steroids could delay the onset of loss of ambulation as much as three years. So, you don't want to deprive patients of the chance to get that. And then all the newer emerging therapies---which we'll be talking about later, I'm sure---require a Duchenne muscular dystrophy diagnosis. So, that's why it's so important to check a CK, have this on your radar, and then get them to a good specialist. Dr Nevel: I know that you alluded already, or shared a few of the kind of exam paroles or findings among patients with dystrophinopathy. But could you share with us a little bit more how you approach these patients in the clinic who are presenting with muscle weakness, perhaps? And how do you approach this or think about this in terms of ways to potentially differentiate between a dystrophinopathy versus another cause of motor weakness or delay? Dr Jayaraman: It's helpful to think through the neuraxis and what kinds of disorders can present along that neuraxis. A major differential that I'm always thinking about when I'm seeing a child with proximal weakness is spinal muscular atrophy, which is a genetic anterior horn cell disorder that can also present in this age group. And some of the key differences there would be things like reflexes. So, you should have dropped reflexes in spinal muscular atrophy. In DMD, surprisingly, they might have preserved Achilles reflexes even if their patellar reflexes are lost. It may only be much later that they go on to lose their Achilles reflex. So, if you can get an Achilles reflex, that's quite reassuring, and if you cannot, then you need to be thinking about spinal muscular atrophy. They can both have low muscle tone and can present quite similarly, including with proximal weakness, and can even have neck flexion weakness. So, this is an important distinction to make. The reason for that is, obviously there are treatments for both conditions, but for spinal muscular atrophy, timing is very, very important. Time is motor neurons, so the sooner you make that diagnosis the better. Other considerations would be the congenital muscular dystrophies. So, for those that they tend to present a lot younger, like in infancy or very early on, and they can have much, much higher CKS in that age range than a comparable Duchenne or Becker muscular dystrophy patient. They can also have other involvement of the central nervous system that you wouldn't see in the dystrophinopathies, for example. My mnemonic for the congenital muscular dystrophies is muscle-eye-brain disease, which is one of the subtypes. So, you think about muscle involvement, eye involvement, and brain involvement. So, they need an ophthalmology valve. They can have brain malformations, which you typically don't see in the dystrophinopathies. I think those are some of the major considerations that I have. Obviously, it's always good to think about the rest of the neuraxis as well. Like, could this be a central nervous system process? Do they have upper motor neuron signs? But that's just using all of your exam tools as a neurologist. Dr Nevel: Yeah, absolutely. So, let's say you have a patient in clinic and you suspect they may have a dystrophinopathy. What is your next diagnostic step after your exam? Maybe you have an elevated CK and you've met with the patient. What comes next? Dr Jayaraman: Great question. So, after the CK, my next step is to go to genetics. And this is a bit of a change in practice over time. In the past we would go from the CK to the muscle biopsy before genetic testing was standard. And I think now, especially in kids, we want to try and spare them invasive procedures where possible. So, genetic testing would be the next step. There are a few no-charge, sponsored testing programs for the dystrophinopathies and also for some of the differential diagnosis that I mentioned. And I think we'll be including links to websites for all of these in the final version of the published article. So, those are a good starting point for a genetic workup. It's really important to know that, you know, deletions and duplications are a very common type of mutation in the DMD gene. And so, if you just do a very broad testing, like whole exome, you might miss some of those duplications and deletions. And it's important to include both checking for duplications and deletions, and also making sure that the DMD gene is sequenced. So always look at whatever genetic test you're ordering and making sure that it's actually going to do what you want it to do. After genetics, I think that the sort of natural question is, what if things are not clear after the genetics for some reason? We still use biopsy in this day and age, but we save it for those cases where it's not entirely clear or maybe the phenotype is a little bit discordant from the genotype. So, for mutations that disrupt the reading frame, those tend to cause Duchenne muscular dystrophy, whereas mutations that preserve the reading frame tend to cause Becker muscular dystrophy. There are some important exceptions to this, which is where muscle biopsy can be especially helpful in sorting it out. So, for example, there are some early mutations early in the DMD gene where, basically, they find an alternate start codon or an initiation codon to continue with transcription and translation. So, you end up forming a largely functional, somewhat truncated protein that gives you more of a milder Becker phenotype. On the other hand, you can have some non-frameshift or inframe mutations that preserve the reading frame, but because they disrupt a very key domain in the protein that's really crucial for its function, you can actually end up with a much more severe Duchennelike phenotype. So, for these sorts of cases, you might know a priori you're dealing with them, but might just be a child who is who you think has DMD has a mutation that's showed up on testing. There isn't enough in the literature to point you one way or another, but they look maybe a little milder than you would expect. That would be a good kid to do a biopsy in because there are treatment decisions that hinge on this. There are treatments that are only for Duchenne that someone with a milder phenotype would not be eligible for. Dr Nevel: So, that kind of stepwise approach, but maybe not all kids need a muscle biopsy is what I'm hearing from you. If it's a mutation that's been well-described in the literature to be fitting with Duchenne, for example. Dr Jayaraman: Absolutely. Dr Nevel: So, after you confirm the diagnosis through genetic testing---and let's say, you know, whether or not you do a muscle biopsy or not, after you know the diagnosis is a dystrophinopathy---how do you counsel the families and your patients? What are the most important points to relay to families, especially in that initial phase where the diagnosis is being made? Dr Jayaraman: This is a lot of what we do in pediatric neurology in general, right? So, I actually picked up this approach from the pediatric hematology oncology specialists at Boston Children's. They had this concept of a day-zero conversation, which is the day that you disclose the life-changing diagnosis or potentially, at some point, terminal diagnosis to a family. And some of the key components of that are a not beating around the bush, telling them what the diagnosis is, and then letting them have whatever emotional response they're going to have in the moment. And you may not get much further than that, but honestly, you want them to take away, this is what my child has. I did not do anything to cause this, nor could I have done anything to prevent this. Because often for these genetic conditions, there's a lot of guilt, a lot of parental guilt. So, you want to try and assuage that as much as possible. And then to know that they're not going to be alone on this journey; that, you know, they don't have to have it all figured out right then, but we can always come back and answer any questions they have. There's going to be a whole team of specialists. We're going to help the family and the kid manage this condition. Those are sort of my big takeaways that I want them to get. Dr Nevel: Right. And that segues into my next question, which is, who is part of that team? I know that these teams that help take care of people with dystrophinopathies and other muscle disorders can be very large teams that span multiple specialists. Can you talk a little bit more about that for this group of patients? Dr Jayaraman: Of course. So, the neuromuscular neurologist, really, our role is in coordinating the diagnosis, the initiation of any disease-specific treatments, and coordinating care with a whole group of specialists. So, we're sort of at the center of that, but everyone else is equally important. So, the other specialists include physical therapists; occupational therapists; rehab doctors or physiatrists; orthotists who help with all of the many braces and other devices that they might need, wheelchairs; pulmonology, of course, for managing the respiratory manifestations of this. It becomes increasingly important over time, and they are involved early on to help monitor for impending respiratory problems. Cardiac manifestations, this is huge and something that you should be thinking about even for your female carriers, the mother of the patient you're seeing in the clinic, or your patient who comes to adult clinic with asymptomatic hyperCKemia. if you end up making a diagnosis of DMD carrier for those patients, or if you make a Becker diagnosis, the cardiac surveillance is even more important because the cardiac involvement can be out of proportion to the skeletal muscle weakness. And of course, extremely important for the Duchenne patients as well. Endocrinologists are hugely important because in the course of treating patients with steroids, we end up giving them a lot of iatrogenic endocrinologic complications. Like they might have delayed puberty, they might have loss of growth, of height; and of course metabolic syndrome. So, endocrinology is hugely important. They're also important in managing things like fracture prevention, osteoporosis, prescribing bisphosphonates if necessary. Nutrition and GI are also important, not just later on when they might need assistance to take in nutrition, whether that's through tube feeds, but also earlier on when we're trying to manage the weight. Orthopedics, of course, for the various orthopedic complications that patients develop. And then finally, a word must be said for social work and behavioral and mental health specialists, because a lot of this patient population has a lot of mental health challenges as well. Dr Nevel: After you give the diagnosis, you've counseled the patient and families and you've had those kind of initial phase discussions, the day-zero discussion, when you start getting into discussions or thoughts about management, disease-specific medication. But what are the main categories of the treatment options, and maybe how do you kind of approach deciding between treatment options for your patients? Dr Jayaraman: So, there are two broad categories that I like to think about. So, one is the oral corticosteroids and oral histone deacetylase, or HDAC inhibitors, which share the common characteristic that they are non-mutation specific. And within corticosteroids, patients now have a choice between just Prednisone or Prednisolone, or Deflazacort or Vermilion. The oral HDAC inhibitors are newly FDA-approved as a nonsteroidal therapy in addition to corticosteroids in DMD patients above six years of age. I would say we're in the early phase of adoption of this in clinical practice. And then the other big category of treatment options would be the genetic therapies as a broad bucket, and this would include gene therapy or gene replacement therapy, of which the most famous is the microdystrophin gene therapy that was FDA-approved first on an accelerated approval basis for ages four to eight, and then a full approval in that age group as well as an accelerated approval for all comers, essentially, with DMD. This is obviously controversial. Different centers approach this a bit differently. I think our practice at our site has been to focus on the ambulatory population, just thinking about risk versus benefit, because the risks are not insignificant. So really this is something that should be done by experienced sites that have the bandwidth and the wherewithal to counsel patients through all of this and to manage complications as they arise with regular monitoring. And then another class that falls within this broader category would be the Exon-skipping therapies. So as the name suggests, they are oligonucleotides that cause an Exon to be skipped. The idea is, if there is a mutation in a particular Exon that causes a frame shift, and there's an adjacent Exon that you can force skipping of, then the resulting protein, when you splice the two ends together, will actually allow restoration of the reading frame. I think the picture I want to paint is that there's a wide range of options that we present to families, not all of which everyone will be eligible for. And they all have different risk profiles. And I really think the choice of a particular therapy has to be a risk-benefit decision and a shared decision-making process between the physician and the family. Dr Nevel: What is going on in research in this area? And what do you think will be the next big breakthrough? I know before we started the recording you had mentioned that there's a lot of things going on that are exciting. And so, I'm looking forward to hearing more. Dr Jayaraman: Of course. So, I'll be as quick as I can with this. But I mentioned that next-generation Exon skipping therapies, I think the hope is that they will be better at delivering the Exon skipping to the target tissue and cells and that they might be more efficacious. I'm also excited about next-generation gene therapies that might target muscle more specifically and hopefully reduce the off-target effects, or combination use of gene therapies with other immunosuppressive regimens to improve the safety profile and maybe someday allow redosing, which we cannot do currently. Or potentially targeting the satellite cells, which are the muscle stem cells, again, to improve the long term durability of these genetic therapies. Dr Nevel: That's great, thank you for sharing. Thank you so much for talking to me today about your article. I really enjoyed learning more about the dystrophinopathies. Today I've been interviewing Dr Divya Jayaraman about her article on the dystrophinopathies, which she wrote with Dr Partha Ghosh. This article appears in the October 2025 Continuum issue on muscle and neuromuscular junction disorders. Please be sure to check out the Continuum Audio episodes from this and other issues. Also, please read the Continuum articles for more details than what we were able to get to today during our discussion. Thank you, as always, so much to the listeners for joining us today, and thank you, Divya, for sharing all of your knowledge with us today. Dr Jayaraman: Thank you so much for having me on the podcast. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

About Ramki JayaramanRamki Jayaraman is the Managing Director of Synarchy Consulting, with more than two decades of experience guiding organizations through leadership challenges, strategy execution, and large-scale transformations. From his early roots in India to his professional journey in Dubai and across Africa, Ramki has built a career helping corporates, governments, and entrepreneurs navigate complexity with clarity.His approach blends strategic foresight with a human-centered perspective, ensuring that innovation and execution go hand in hand. Over the years, he has led projects in diverse markets, always emphasizing context, adaptability, and empowerment. Whether advising family businesses in transition or shaping government reforms, Ramki's passion lies in turning strategy into measurable results.About this EpisodeIn this inspiring episode of The Matrix Green Pill Podcast, host Hilmarie Hutchison speaks with Ramki about his journey from corporate life to entrepreneurship and the lessons he's learned leading transformations across the Middle East and Africa.Ramki shares insights on shifting leadership models, the importance of execution, and the link between digital transformation and employee well-being. He introduces his 70-20-10 framework for resilience, highlights common leadership blind spots, and explains why empowering people is the key to lasting success.Quotes2:03 - I think I'm a builder at heart. 2:56 - Approach has always been a boutique approach to execution. 4:51 – Leadership is all about building cross-border teams, it's about cross-organizational structures. 5:05 - We need to adapt, we need to carry everybody together in this journey of leadership. 6:41 - To build an organizational resilience, especially in times like these, with disruptions and technology, we need to put a formula called as a 70-20-10, where you spend 70% of your growth should come from what we call as a core business, 20% of your business should come from what I call as a growth business or a new growth areas or diversification. 10:21 - Rather than taking a decision structure sitting at the top and then about people, working with people would probably be the only way organizations will thrive in the future. 11:52 - It's important to have global thinking so that you don't reinvent everything, because if you keep reinventing everything you can't build an organization at scale. 12:54 - That's one blind spot which I generally see where organizations tend to be more focused on activity and ignoring the impact.14:05 - When you have that outcome-based assessment, and that's when you'll be able to distill these activities, and then all these activities should result in an impact or an outcome.14:19 - They're the leaders of the future A and they are the stability carriers of organizations. Every organization will have a typical pyramid structure. 14:48 - If you don't invest heavily in middle management and then they become your weakest link.15:00 - It's also about building their trust as well, because then you're trying to build a very committed and an invested middle management to take the organization to the next goalpost that they've set for themselves. 15:43 - We work with the leadership, we work with the board, we work with the client management to build an execution roadmap and that's a big pivot that we're seeing in terms of adopting AI in our core workforce. 16:55 - It's not that AI is not going to replace humans. You're possibly going to be replaced by a person who is using AI better.17:27The Matrix Green Pill Podcast: https://thematrixgreenpill.com/Please review us: https://g.page/r/CS8IW35GvlraEAI/review

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers goals of care conversations.Our guest for this episode is Dr. Tavis Apramian, a clinician-investigator in the Department of Family & Community Medicine (DFCM) at the University of Toronto and scientist in the Office of Education Scholarship. He works as a palliative care physician at St. Michael's Hospital and at Kensington Hospice. His largely qualitative program of research is focused on advance care planning; workplace-based learning and assessment; palliative care in family medicine; medical assistance in dying; and inequity in end-of-life care. His primary focus is on telling rich stories of learner and patient experiences to spark conversation about socioculturally complex educational and clinical problems in serious illness.The learning objectives for this episode are as follows:Describe a palliative approach to care and its relevance across different contextsDemonstrate a structured and compassionate approach to goals of care conversationsApply effective communication strategies to build therapeutic alliance, navigate difficult conversations, and involve multiple actors in the palliative contextRecognize and manage challenges in goals of care conversationsGuest: Dr. Tavis ApramianHosts: Dr. Daamoon Ghahari (PGY2) and Dr. Angad Singh (PGY2)Audio editing: Dr. Angad Singh (PGY2)Timestamps:(1:07) - Journey to palliative care(5:07) - What is palliative care(14:47) - Understanding patient values(33:47) - Structuring goals of care conversations(44:16) - Communication strategies(57:05) - Navigating family meetings(77:25) - Reflections on MAiD for sole mental illnessResources:Roth, H. (2024). Hearing the unspoken. Canadian Family Physician, 70(10), 642-642. https://pmc.ncbi.nlm.nih.gov/articles/PMC11477260/pdf/0700642.pdfReferences:Bernacki, R. E., & Block, S. D. (2014). Communication about serious illness care goals: a review and synthesis of best practices. JAMA internal medicine, 174(12), 1994-2003.Gross, J., & Koffman, J. (2024). Examining how goals of care communication are conducted between doctors and patients with severe acute illness in hospital settings: A realist systematic review. PLoS One, 19(3), e0299933.Scheunemann, L. P., Ernecoff, N. C., Buddadhumaruk, P., Carson, S. S., Hough, C. L., Curtis, J. R., ... & White, D. B. (2019). Clinician-family communication about patients' values and preferences in intensive care units. JAMA internal medicine, 179(5), 676-684.You, J. J., Downar, J., Fowler, R. A., Lamontagne, F., Ma, I. W., Jayaraman, D., ... & Canadian Researchers at the End of Life Network (CARENET). (2015). Barriers to goals of care discussions with seriously ill hospitalized patients and their families: a multicenter survey of clinicians. JAMA Internal Medicine, 175(4), 549-556.For more PsychEd, follow us on Instagram (⁠@psyched.podcast⁠),  Facebook (⁠PsychEd Podcast⁠), X (⁠@psychedpodcast⁠), and Bluesky (⁠@psychedpodcast.bsky.social‬⁠). You can email us at ⁠psychedpodcast@gmail.com⁠ and visit our website at⁠ ⁠⁠psychedpodcast.org⁠.

Vijay Prashad talks with Class Unity about the politics and economics of imperialism as well as issues with the contemporary left. He is the author of many books, including: (2011) Marx's Capital: An Introductory Reader. Contributed by Vijay Prashad, Venkatesh Athreya, Prasenjit Bose, Prabhat Patnaik, Jayati Ghosh, T. Jayaraman, R. Ramakumar. LeftWord.(2015) Letters to Palestine. […]

We've all heard the story: In a fair market, workers are paid exactly what they're worth. Economists even have a name for it—marginal productivity theory. It's neat, simple…and completely wrong. In this Back-to-Basics episode, economist Marshall Steinbaum and labor leader Saru Jayaraman dismantle the myth that the market fairly rewards labor. Steinbaum reveals how this theory has been weaponized to excuse wage stagnation, justify corporate power, and erode worker bargaining rights. Jayaraman shows what that looks like in the real world, from restaurant workers stuck at subminimum wages to entire industries built on underpaying the people who keep them running. They make the case that your paycheck isn't determined by some neutral law of economics—it's the result of choices, policies, and power dynamics that can be rewritten to ensure everyone is truly paid what they're worth. Marshall Steinbaum is an Associate Professor of Economics at the University of Utah and a Senior Fellow in Higher Education Finance at the Jain Family Institute. Saru Jayaraman is an attorney, President of One Fair Wage and the Restaurant Opportunities Centers United (ROC United), and author of One Fair Wage: Ending Subminimum Pay in America.  Social Media:  @Econ_Marshall ‪@econmarshall.bsky.social‬ @SaruJayaraman Further reading:  One Fair Wage: Ending Subminimum Pay in America Website: http://pitchforkeconomics.com Instagram: @pitchforkeconomics Threads: pitchforkeconomics Bluesky: @pitchforkeconomics.bsky.social TikTok: @pitchfork_econ Twitter: @PitchforkEcon, @NickHanauer, @civicaction YouTube: @pitchforkeconomics LinkedIn: Pitchfork Economics Substack: ⁠The Pitch⁠

Kudumba Thozhil by Jayaraman Raghunathan - குடும்பத் தொழில் - ஜெயராமன் ரகுநாதன் - Tamil Short Story

In today's episode of The Other Way, I'm joined by Sahana Jayaraman as we dive into the often invisible and emotional journey of infertility. Sahana shares her deeply personal experience of undergoing seven rounds of IVF, nine embryo transfers, three miscarriages, and one ectopic pregnancy. This conversation is not just about her story but also about shedding light on the silence that surrounds infertility, the myths about female timelines, and the societal narratives that need shifting. We talk about raw truths, real stats, and the emotional and physical toll of fertility treatments. If you're on your own fertility journey or know someone who is, this episode provides valuable insights and a powerful message of resilience and hope. Join us as we honor the non-linear paths to motherhood and the strength it takes to hold onto oneself through it all.About Sahana:Sahana is an entrepreneur, strategist, and storyteller who navigates both personal and professional challenges with authenticity and passion. As the founder Zagging Goats, she helps startups and innovators craft bold, breakthrough brand strategies – guiding them to think differently and solve real business problems with bold messages and storytelling, even when it means zagging when others zig.Beyond her career leading brand marketing for more than 20 years, Sahana has built her own personal brand through LoveSahana - a creative project centered around themes of love, connection, and personal growth. Recently on her Instagram channel @Love_Sahana, Sahana shares real talk about her own deeply personal experience with fertility and the IVF journey. By sharing her story, she hopes to foster connection and remind others that they're not alone in navigating the complexities of fertility.Whether she's building brands or sharing her own path, Sahana's mission is clear: to inspire others to live authentically, lead with love, and embrace the mindset shifts that fuel growth.To connect with Sahana:IG: Love_SahanaLI: linkedin.com/in/sahanajayaraman

ViolinSupport the show

Today's guest is Swami Jayaraman, Senior Vice President and Chief Enterprise Architect at Iron Mountain. Iron Mountain is a publicly traded global leader in storage and information management services trusted by over 240,000 organizations worldwide, including 90% of the Fortune 1000 for over 70 years. Swami returns to the program to talk about use cases in risk management, cybersecurity, and customer experience in financial services spaces – and what they can tell financial leaders about the concrete abilities of AI to unlock efficiencies in these areas. Together with Emerj Senior Editor Matthew DeMello, Swami overviews how AI can analyze ID documents, monitor loan agreements, and automate regulatory reporting. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Today's guest is Swami Jayaraman, Senior Vice President and Chief Enterprise Architect at Iron Mountain. Iron Mountain is a publicly traded global leader in storage and information management services trusted by over 240,000 organizations worldwide, including 90% of the Fortune 1000. Swami joins us on today's show to talk about risk management challenges in financial services, including cybersecurity, regulatory compliance, people and culture, technology adoption, and data management. Later, we explore AI's impact on customer experience and compliance workflows in ways that are helping financial leaders surmount these challenges. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

In our 12th episode, Katia Halabi and Raji Jayaraman explain and discuss research-practice partnerships (RPPs) and share their experiences. Katia is a practitioner and head of the TVET (technical and vocational education and training) component of a project commissioned by the German Federal Ministry for Economic Cooperation and Development (BMZ) and implemented by the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) in Rwanda with co-funding by the European Union. Raji is a researcher and professor of economics at ESMT Berlin as well as the co-director of the Forward Society Lab. We explore the characteristics of RPPs, and how such a partnership is implemented in an ongoing project in Rwanda. We delve into the role of quantitative data and rigorous evidence in policymaking and of course discuss how this is linked to financing impact with taxpayers' money. Links ·       The Forward Society Lab Time stamps On some podcast players, you should be able to jump to the section by clicking: (01:24) – Raji and Katia introduce themselves (02:11) – Raji explains what a research-practice partnership (RPP) is (02:47) – The role of rigorous evidence to inform policy decisions (03:44) – Katia shares her motivation as a practitioner to engage in an RPP (05:00) – The matchmaking exercises that brough practitioners and researchers together (07:22) - Katia explains the context of the project she is working on in Rwanda (09:43) – Raji explains what is evaluated in this RPP: whether training makes a difference for both teachers' pedagogy as well as students' learning outcomes (10:37) - The role of randomization to generate rigorous evidence (12:56) - Katia describes the motivation of the Rwanda government to learn from the RPP (14:32) – Raji on the necessity for research to speak to concerns of citizens and marginalized communities (17:36) – Katia on why the use of taxpayers' money should be evaluated (21:09) – Raji shares examples of things that cannot be evaluated through an RCT (randomized control trial) (23:47) – Success factors for collaboration between researchers and practitioners (29:04) – What happens after an RPP (32:35) – Differences between countries when it comes to research informing policy (35:32) – RPPs are not exclusive to development cooperation (36:43) – The role of AI for research   Contact For feedback on the show or to suggest guests for future episodes, contact us at scifi@esmt.org      

From saving Valentine's Day with last-minute flower deliveries to ensuring your picnic continues uninterrupted with snacks delivered via drone, Walmart redefines convenience. We discuss with Vijay Jayaraman, Senior Director of Product at Walmart eCommerce, how these strategies are implemented across 4500 stores to create seamless, memorable customer experiences.In this episode of a new 5-part series, Elevating to the C-Suite, Vijay talks about Continuous Digital Optimization (CDO), strategies for eliminating customer friction, evolving with customer needs, and harnessing technology and insights to revolutionize the customer experience.Listeners will learn:How Walmart leverages its extensive store network to facilitate same-day deliveries, offering solutions that exceed traditional online shopping expectations.The impact of advanced technologies like drone deliveries on everyday convenience, and how these innovations are integrated into Walmart's customer service strategy.Strategies Walmart employs to handle potential disruptions and ensure a seamless return process, enhancing overall customer satisfaction and loyalty. 

In recognition of Stroke Awareness Month and Survive Stroke Week, this week's guest on FOX Rehabilitation's Live Better Longer podcast is distinguished neuroradiologist, Mahesh Jayaraman, MD, FACR, who explains the importance of acting quickly whenever someone experiences a sign of having a stroke, which could include a loss of balance, blurry vision, a drooping of one's face, arm weakness, or speech difficulty. Dr. Jayaraman talks about what first got him interested in studying the brain and how he became an advocate for stroke education. Likening them to a top-notch NASCAR pit crew, Dr. Jayaraman also discusses how a team of medical professionals jump into action after receiving a 911 call for someone who is thought to be having a stroke. Listen to this week's episode and learn what you need to do if you or someone you know is showing any symptoms of a stroke.

In recognition of Stroke Awareness Month and Survive Stroke Week, this week's guest on FOX Rehabilitation's Live Better Longer podcast is distinguished neuroradiologist, Mahesh Jayaraman, MD, FACR, who explains the importance of acting quickly whenever someone experiences a sign of having a stroke, which could include a loss of balance, blurry vision, a drooping of one's face, arm weakness, or speech difficulty. Dr. Jayaraman talks about what first got him interested in studying the brain and how he became an advocate for stroke education. Likening them to a top-notch NASCAR pit crew, Dr. Jayaraman also discusses how a team of medical professionals jump into action after receiving a 911 call for someone who is thought to be having a stroke. Listen to this week's episode and learn what you need to do if you or someone you know is showing any symptoms of a stroke.

In recognition of Stroke Awareness Month and Survive Stroke Week, this week's guest on FOX Rehabilitation's Live Better Longer podcast is distinguished neuroradiologist, Mahesh Jayaraman, MD, FACR, who explains the importance of acting quickly whenever someone experiences a sign of having a stroke, which could include a loss of balance, blurry vision, a drooping of one's face, arm weakness, or speech difficulty. Dr. Jayaraman talks about what first got him interested in studying the brain and how he became an advocate for stroke education. Likening them to a top-notch NASCAR pit crew, Dr. Jayaraman also discusses how a team of medical professionals jump into action after receiving a 911 call for someone who is thought to be having a stroke. Listen to this week's episode and learn what you need to do if you or someone you know is showing any symptoms of a stroke.

Dr. Mahesh V. Jayaraman - On The Front Porch [00:00:00] Dr. Mahesh V. Jayaraman - On The Front Porch [00:11:20] ON THE FRONT PORCH 2 [00:22:24] ON THE FRONT PORCH 3 [00:32:41] ON THE FRONT PORCH 4See omnystudio.com/listener for privacy information.

Host Dr. Joel Berg is joined by Dr. Jayakumar Jayaraman to discuss ongoing research delving into utilizing dental dentition as a tool to assess age and other health factors. Dr. Jayaraman shares details of finding thus far and how the information can be more broadly used to support the one in four children in developing countries who are unsure of their birth date, a major roadblock for refugees and immigration processes. Guest Bio: Dr. Jayakumar Jayaraman is a board certified Pediatric Dentist with extensive clinical and research training from various prestigious institutions around the world. He holds master's degrees in Pediatric Dentistry from the University of Hong Kong and the University of Texas Health San Antonio. Additionally, he obtained his Diploma in Pediatric Dentistry and Fellowship at the Royal College of Surgeons of Edinburgh, Scotland, where he also serves as an Examiner. Over the past 15 years, Dr. Jayaraman has been actively involved in teaching pediatric dentistry and supervising research projects for students at different academic levels in multiple countries. His research interests encompass a wide range of topics including Evidence-Based Dentistry, Forensic Dentistry, Human Biology, and Anthropology. With over 75 peer-reviewed scientific articles published, he is also actively involved as an editorial board member for leading forensic and pediatric dental journals. Furthermore, Dr. Jayaraman plays a significant role in various dental organizations, serving as a member of the Scientific Committee of the International Association of Paediatric Dentistry and as an expert consultant for the Council of Scientific Affairs of the American Academy of Pediatric Dentistry. He was recently elected as a Fellow of American Academy of Forensic Sciences. Dr. Jayaraman holds the position of Associate Professor & Director of Research in the Department of Pediatric Dentistry at Virginia Commonwealth University, Richmond, VA, while also practicing at a pediatric dental clinic in Williamsburg, VA. He is the Founder & Director of Date of Birth Foundation (www.dobfoundation.org), the world's first charity to promote accurate birth records.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join us for a new edition of our global surgery series! On this episode, Dr. Jon Williams is joined by Dr. Sudha Jayaraman and Dr. Justina Seyi-Olajide to discuss how we define global surgery today and how health infrastructure interacts with global surgical care.  Dr. Jayaraman is a trauma and acute care surgeon at University of Utah, and the director of the Center for Global Surgery. After attending UC Davis for medical school, Dr. Jayaraman completed general surgery residency at UCSF, during which time she obtained a masters in public health in developing countries from the London School of Hygiene and Tropical Medicine. During this time, her efforts were dedicated to researching and implementing trauma systems development in Uganda. After residency she then completed a trauma and critical care fellowship at Brigham and Women's, during which she received the Harvard Medical School Health Disparities Fellowship to continue her trauma systems work in Rwanda. Her ongoing work investigating injury burden and trauma systems in low and middle income countries has been well funded by the NIH, DOD, and others and published in numerous forums, as she is a well-renowned expert in this field.  Dr. Justina Seyi-Olajide is a pediatric surgeon at the Lagos University Teaching Hospital in Lagos, Nigeria. She completed her medical school training at the Ahmadu Bello University in Zaria, Nigeria and subsequently her general surgical and pediatric surgical training at the Lagos University Teaching Hospital, earning the Fellowship of West African College of Surgeons in Pediatric Surgery and the Alinta Nwako prize for best graduating pediatric surgical trainee. Dr. Seyi-Olajide's vision is to provide equitable pediatric surgical care in resource-limited settings, and has been highly influential for developing initiatives such as the National Surgical, Obstetric, Anesthesia and Nursing Plan for Nigeria. Additionally, she is a member of the Global Initiative for Children's Surgery and is well published for her original research on topics regarding access to pediatric surgical care in low and middle income countries.  Have any feedback for the global surgery content, or have any suggestions for future episodes? Please feel free to reach out to us at hello@behindtheknife.org. We now have over 725 episodes!  The easiest way to find specific topics or episodes is on our website https://app.behindtheknife.org/home or on our new Apple/Android app.  You can search or browse by topic, podcast series, etc., making it much easier to navigate than podcast players.  iOS: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android: https://play.google.com/store/apps/details?id=com.btk.app PREMIUM BUNDLE: https://app.behindtheknife.org/bundle/95 Please email hello@behindtheknife.org to learn more about our premium bundle and institutional discounts. Premium Bundle Includes: General Surgery Oral Board Audio Review Trauma Surgery Video Atlas Colorectal Surgery Oral Board Audio Review Surgical Oncology Surgery Oral Board Audio Review Vascular Surgery Surgery Oral Board Audio Review Cardiothoracic Surgery Surgery Oral Board Audio Review

Arjun Jayaraman, portfolio manager at Causeway Capital Management, says that valuations abroad are better than what investors are seeing domestically -- noting that international small cap stocks are trading at a discount of 10 times compared to domestic large-cap companies -- but made it clear he favors Japan and India while worrying that geopolitical issues are making it difficult to invest in China despite compelling valuations that have it among the cheapest nations in the world. Plus, Kyle Guske, investment analyst at New Constructs, puts Reddit's upcoming initial public offering into the Danger Zone, Chuck discusses the bad banking pitch wrapped in a flag by a new bank trying to capitalize on political disagreement, and Bryan Wong, co-manager of Osterweis Emerging Opportunity, talks small-cap stocks in the Market Call.

On “Food Talk with Dani Nierenberg,” Dani speaks with Saru Jayaraman, President of One Fair Wage, an organization working to end subminimum wages in the United States. They discuss the inspiring progress that workers have celebrated, why the only future for the restaurant industry is one that provides life-sustaining wages to employees, and what it means to be a part of the fight for fair pay at a time when, as Jayaraman says, “we're finally winning.” While you're listening, subscribe, rate, and review the show; it would mean the world to us to have your feedback. You can listen to “Food Talk with Dani Nierenberg” wherever you consume your podcasts.

Welcome to to episode 31 of First Principles! If you've been listening to us for a while, you'll notice that this was supposed to be an off week for us as a fortnightly show. We used to release new episodes every other Thursday. And last Thursday was our episode with Ritesh Agarwal of OYO Rooms.  But starting this week, First Principles is now a weekly podcast. We're going to bring you a fresh conversation every Thursday.  But in a slightly different way. Well, the supply of truly original, accomplished and candid founders and business leaders in India is what we believe, a finite resource. So while we'd love to – at some point – have a roster of guests talking to us every single week, that isn't possible right now.  And so, we're now increasing the duration of our conversations with the leaders we meet to roughly two hours each.  Only to split it into two distinct conversations and episodes.  That's where this episode comes in. A couple of weeks ago you heard our episode with Karthik Jayaraman – the co-founder and CEO of WayCool Foods, an agri-tech start up that distributes and processes fresh produce, grains, staples and milk. It was a wonderfully candid and authentic conversation in which Karthik spoke about complementing, instead of disrupting; treading lightly while making decisions; and starting up at 40.In fact, we'd urge you to check out the episode – or, if you'd like to go through the full transcript. You can click here to do so. But what you didn't hear in that conversation is what we're releasing today as episode 31.  We talk about why Karthik took such a big risk at 40 by jumping from automobiles into a completely different sector, agri-tech. He also reflects on his career, what got him here, and what keeps him going.  We talked about who Karthik is – as a leader and a CEO. What are the habits that he's picked up? What has he been reading, and why? We've tied all of this together for today's episode – a Part 2, on Karthik's life, career and values.  Check out the First Principles Newsletter, a weekly Sunday read on entrepreneurship, mental models, leadership and reflection here.Send in submissions for books recommendations, interesting reads, Silent Sunday pictures or songs for the First Principles newsletter here.This is episode 31 of First Principles with Karthik Jayaraman, Part 2—The Ken's fortnightly leadership podcast.The Ken is India's first subscriber-only business journalism platform. Check out our deeply reported long-form stories, insightful newsletters, original podcasts and much more here.

Rolls-Royce, a venerable name synonymous with engineering, excellence, and innovation, has not only graced the automotive world with luxurious automobiles but has also soared to remarkable heights in the aerospace and defence sectors. Beyond its legacy of crafting powerful engines and iconic luxury cars, Rolls-Royce is emerging as a trailblazer in the pursuit of sustainability within the aerospace industry. Join us as we unravel the dynamic world of aerospace with Kishore Jayaraman, the distinguished President of Rolls-Royce for India & South Asia. From discussing Rolls-Royce's groundbreaking sustainability initiatives to exploring the future of electrification in aviation, he shares insights into fostering innovation and collaboration.  [00:33] - About Kishore Jayaraman, OBE Kishore is the President of India and South Asia for Rolls-Royce. He was earlier the President and CEO of GE Energy in South Asia. He has recently been awarded an honourary officer of the Order of the British Empire (OBE) by Her Majesty for services to international trade and investment with a key focus on the promotion of Indian UK trade. --- Support this podcast: https://podcasters.spotify.com/pod/show/tbcy/support

Welcome to Episode 29 of First Principles.Our guest for this episode is Karthik Jayaraman, the co-founder and MD of WayCool Foods.Karthik's leadership style and philosophies differ from many of the earlier leaders and founders featured in the last 28 episodes of First Principles. Perhaps it's because he started WayCool, an agri-tech startup, after turning 40. Karthik jokes that some people buy a Ferrari as a response to their midlife crisis. Instead, he decided to start up.WayCool was last valued at over $700 million. It's headquartered in Chennai and focused on South India. It's a distributor and processor of fresh produce greens, staples and milk, and though it operates from farm to fork, it is a supply chain company at its heart, says Karthik.One that tries to predict the demand from retailers and consumers and then works backwards to source the supply. I know this might sound complex, but Karthik explains it really well. And when he does, you'll notice he has a very keen understanding of supply chains.That's because before starting an agri-tech company, Karthik had been in the automotive industry for nearly 20 years. He's also spent time as a consultant with McKinsey.Perhaps this offbeat combination makes him somewhat different from many founders, which, in turn, leads to a set of contrary but humbly held perspectives on business and startups.For instance, Karthik talks about how he's built WayCool, not to be disruptive but to complement the geographies it is in. It's a business that sways with the landscape and tries to tread lightly.Karthik is also a founder who doesn't hesitate to admit where he's made mistakes before or where there are still opportunities to learn.In this conversation, Karthik talks about:Two questions he asks to find out if an idea is truly novelHow do you build a brand when it comes to staple products where every commodity is similar?How does he observe, learn, document and implement knowledge?And what is the job of a CEO?This is Episode 29 of First Principles—The Ken's fortnightly leadership podcast.The Ken is India's first subscriber-only business journalism platform. Check out our deeply reported long-form stories, insightful newsletters, original podcasts and much more here.

Join us today as we speak with Smriti Jayaraman, investor at Corazon Capital about consumer & impact innovation.

Dr. Jayaraman recommends producers to consider implementing GAA in swine diets. This contributes to superior performance, increased final body weight, and a better gain/feed ratio, thus improving carcass quality, reducing fat thickness, and allowing a reduction in the amount of energy ingredients. This approach also benefits the growth and development of newborn piglets. Have you listened to the whole episode yet?The Swine it Podcast Show is trusted and supported by innovative companies like:-Adisseo-Evonik-AB Vista-Genesus-CloudFarms-Bioverse (Healthy farms)-Schippers-Eastman

The adequate amount of Guanidinoacetic Acid (GAA) plays a key role in maintaining energy homeostasis in cells, resulting in better utilization of nutrients. Feed efficiency, which measures the difference in the responses when using GAA or not, has been widely studied in several trials. According to Dr. Jayaraman, it is possible to observe a significant difference of approximately five to ten points between the control group and those receiving GAA supplementation. Watch the complete episode!The Swine it Podcast Show is trusted and supported by innovative companies like:-Adisseo-Evonik-AB Vista-Genesus-CloudFarms-Bioverse (Healthy farms)-Schippers-Eastman

The role of acetic acid and creatine in animal nutrition, specifically in swine, is a topic of great importance for understanding their physiological functions and optimizing their performance. Acetic acid, a natural precursor, plays a crucial role in the synthesis of creatine, which is essential for maintaining muscular energy homeostasis. In this episode, Dr. Jayaraman delves into the subject of Guanidinoacetic Acid (GAA), discussing its mechanism of action and the significant results observed in animal performance. Check out the complete episode!The Swine it Podcast Show is trusted and supported by innovative companies like:-Adisseo-Evonik-AB Vista-Genesus-CloudFarms-Bioverse (Healthy farms)-Schippers-Eastman

Why not use GAA as a supplement during the finishing phase, especially months before slaughter? Dr. Jayaraman discusses that during this period, improvements have been observed not only in growth performance, but also in carcass quality, especially regarding the increase of the amount of lean meat and the reduction of backfat  thickness. Have you watched the episode yet?The Swine it Podcast Show is trusted and supported by innovative companies like:-Adisseo-Evonik-AB Vista-Genesus-CloudFarms-Bioverse (Healthy farms)-Schippers-Eastman

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2023.07.19.549514v1?rss=1 Authors: Goldschmidt, D., Tastekin, I., Munch, D., Park, J.-Y., Haberkern, H., Serra, L., Baltazar, C., Jayaraman, V., Rubin, G. M., Ribeiro, C. Abstract: Foraging animals must balance the costs of exploring their surroundings with the potential benefits of finding nutritional resources. Each time an animal encounters a food source it must decide whether to initiate feeding or continue searching for potentially better options. Experimental evidence and patch foraging models predict that this decision depends on both nutritional state and the density of available resources in the environment. How the brain integrates such internal and external states to adapt the so-called exploration-exploitation trade-off remains poorly understood. We use video-based tracking to show that Drosophila regulates the decision to engage with food patches based on nutritional state and travel time between food patches, the latter being a measure of food patch density in the environment. To uncover the neuronal basis of this decision process, we performed a neurogenetic silencing screen of more than 400 genetic driver lines with sparse expression patterns in the fly brain. We identified a population of neurons in the central complex that acts as a key regulator of the decision to engage with a food patch. We show that manipulating the activity of these neurons alters the probability to engage, that their activity is modulated by the protein state of the animal, and that silencing these neurons perturbs the ability of the animal to adjust foraging decisions to the fly's travel time between food patches. Taken together, our results reveal a neuronal substrate that integrates nutritional state and patch density information to control a specific foraging decision, and therefore provide an important step towards a mechanistic explanation of the cognitive computations that resolve complex cost-benefit trade-offs. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC

In our new CONVOCO! Podcast Corinne M. Flick speaks with Prof. Raji Jayaraman, Academic Director at the Future Institute for Sustainable Transformation at ESMT Berlin, about:Can We Make Globalization Sustainable?

In Episode 2 of The Health Project, Our Host Shwetambari Shetty is in conversation with an IAFFH Certified Functional Hormone Specialist, Dr Mahesh Jayaraman, who explains why rest is crucial during periods. As a co-founder of Sepalika, a women's hormone health clinic, he has treated conditions like PCOD, infertility & menopausal symptoms. Dr. Mahesh highlights the importance of self-care during menstruation and how it can benefit women's overall health. Listen in for valuable insights and tips on how to rest and take care of yourself during your menstrual cycle. Don't forget to subscribe to our podcast and share it with your loved ones! ..... Follow Dr. Mahesh https://www.instagram.com/sepalikafertility/ Say hi to your host! https://www.instagram.com/shweshetty/ Have feedback or ideas for the show? We'd love to hear from you! Email: hello@cult.fit Twitter: twitter.com/cultfitofficial Instagram: instagram.com/cultfitofficial This episode was recorded, produced & distributed by Trifecta Records India: Instagram: https://www.instagram.com/trifectarecordsindia/ LinkedIn: https://www.linkedin.com/company/trifectarecordsindia/

MJ is an Engineering Manager for the API and Partnerships team at Honeycomb. MJ's team works on exposing APIs and integrating Honeycomb capabilities with the broader software ecosystem to allow users to take advantage of Observability from anywhere!Before Honeycomb, MJ spent 12 years as a consultant, developer, and leader at companies like ThoughtWorks and Apple. Outside work, she enjoys long walks listening to an audiobook or podcast (current phase - true crime or cults). She also loves legos an lazy weekends and binge-watching television shows.We cover a lot, including:regular check-ins about career directionWill Larson's Career Check-upfinancial stabilityartifacts and structuresspecialists and innovationgeneralists and versatilityembracing the way things are done elsewhereappreciating context switchingLara Hogan's Voltron exercisefeeling stuck in a careerhow to recognize a need for changeConnect with MJ on LinkedIn and read more about Honeycomb here.And finally...Looking for new energy in your mentorships? Check out the Plucky Mentor Pack, an easy tool to inspire deep conversations about your path. 

Madhuvanthi Jayaraman graduated from the Joint Program of Biomedical Engineering at UNC and NC State in 2019. Now, she is a Design Control Systems Engineer at Intuitive Surgical. Madhu joins us to talk about her role, building traceability matrices as part of the device design process, and moving across the country for a new job. More on The BME Grad Podcast: www.thebmegradpodcast.com Subscribe on YouTube: www.youtube.com/channel/UCyfF0xH80d5lS1RpQsmpw0Q/videos Follow us on LinkedIn: www.linkedin.com/company/thebmegradpodcast/ Follow us on Instagram: www.instagram.com/thebmegradpodcast/ --- Support this podcast: https://podcasters.spotify.com/pod/show/the-bme-grad/support

Madhuvanthi Jayaraman graduated from the Joint Program of Biomedical Engineering at UNC and NC State in 2019. She now works as a Design Control Systems Engineer with the Tools and Processes team at Intuitive, supporting the development, testing, and implementation of internal tools that help in building documentation and traceability matrices which adhere to the current Design Control Process for medical devices. Madhu joins us to talk about her role, building traceability matrices as part of the device design process, and moving across the country for a new job. More on The BME Grad Podcast: www.thebmegradpodcast.com Subscribe on YouTube: www.youtube.com/channel/UCyfF0xH80d5lS1RpQsmpw0Q/videos Follow us on LinkedIn: www.linkedin.com/company/thebmegradpodcast/ Follow us on Instagram: www.instagram.com/thebmegradpodcast/ --- Support this podcast: https://podcasters.spotify.com/pod/show/the-bme-grad/support

In this episode we discuss interoperability challenges with two leaders from symplr: Brian Fugere, the Chief Product Officer, and Vijay Jayaraman, the Vice President of Strategy, Product Management. Tune in to hear about the implications of healthcare operations technology challenges, how the current fiscal environment impacts hospital adoption of software solutions, and much more.This episode is sponsored by symplr.

This episode of EMS One-Stop with Rob Lawrence is brought to you by Lexipol, the experts in policy, training, wellness support and grants assistance for first responders and government leaders. To learn more, visit lexipol.com.  In this episode of EMS One-Stop, our host, Rob Lawrence, kicks off a series on international EMS, interviewing EMS leaders across the globe on how their systems are operated, the challenges they face and the successes they have had. Rob begins his podcast journey with Rwanda, a country and EMS system close to his heart. Rob has advised the Rwandan EMS system and monitored their progress for many years. In this episode, he welcomes Rwandan EMS Leader Jean Marie Uwitonze from the Rwandan Ministry of Health, Division of EMS; and U.S. Trauma Surgeon Dr. Sudha Jayaraman, director of the Center for Global Surgery at the University of Utah. Rwanda is one of the only countries in Sub-Saharan Africa to have a publicly run, national ambulance service, which was established in 2007. Uwitonze highlights the development of EMS, and training and certification levels in Rwanda, as well as the next major project to develop and enhance emergency communications across the country. Dr. Jayaraman describes her involvement (for over a decade) in the development of EMS in the country and notes, “We all know that there is no point in having a wonderfully qualified surgeon in the hospital if there is no means to get the patient there.”

Karthik Jayaraman, Co-Founder WayCool chats with Gaurav Ranjan, VP Investments Prime Venture Partners.Listen to the podcast to learn about01:30 - Push-Led Supply Chain to Demand Led Supply Chain10:00 - Role of Tech in Food Supply Chain18:00 - Depth in One Category Vs Building Breadth30:00 - Build in-house, Acquire or Use 3rd Party Service Providers?35:00 - Solving Credit for Farmers38:00 - Resource Allocation: Physical CFO & Digital CFO42:00 - “My Job is to Develop Leaders”Click here to read the full transcriptWant to learn more about about AgriTech in India? Listen to this episode with Shashank Kumar, Co-Founder & CEO DeHaat where we talk about Scalability and Monetisation in AgriTech; Role of Tech(Enabler or Revenue Generator); Managing Scale in a Fast Growing Startup; New Startup Opportunities in AgriTech Space and a lot more. ----------We are organising a B2B commerce Roundtable, followed by a mixer, on 7th December in Bangalore. Join us if you are building in the B2B commerce space and would like to get insights from entrepreneurs and investors in the space.  Panelists include:- Sanjay Dasari, Co-Founder WayCool Foods- Nishant Verman, Co-Founder Bzaar- Shashank Singh, Co-Founder Poshn- Shivani Kulkarni, Senior Associate Prime Venture PartnersThis is a curated event and has limited slots. Please register at the earliest to confirm your participation. Register here: https://lu.ma/B2BCommerce----------Enjoyed the podcast? Please consider leaving a review on Apple Podcasts and subscribe wherever you are listening to this.Follow Prime Venture Partners:Twitter: https://twitter.com/Primevp_inLinkedIn: https://www.linkedin.com/company/primevp/ This podcast is for you. Do let us know what you like about the podcast, what you don't like, the guests you'd like to have on the podcast and the topics you'd like us to cover in future episodes. Please share your feedback here: https://primevp.in/podcastfeedback

Episode 37: Arun Jayaraman, PT, PhD - Exec Director, Tech & Innovation Hub at Shirley Ryan Ability Lab Welcome to the 2022 World Stroke Day edition of the Know Stroke Podcast. David and Mike had the privilege of sitting down with a world renowned expert in stroke rehab technology leading innovation at the #1 ranked rehabilitation hospital in the United States. We hope this episode will bring you optimism knowing that passionate leaders like todays guest are at the helm of clinical research. About Our Guest Arun Jayaraman, PT, PhD, is an internationally recognized expert on sensors, exoskeletons, robotics and other emerging rehabilitation technologies. As Executive Director, Technology & Innovation Hub (tiHUB), he collaborates with commercial and academic partners for research collaboration, technology development and clinical outcome evaluation. He also leverages valuable industry and research expertise to accelerate Shirley Ryan AbilityLab's clinical adoption of next-generation rehabilitation technologies. Since joining Shirley Ryan AbilityLab in 2008, Dr. Jayaraman also has served as Director of the Max Näder Lab for Rehabilitation Technologies and Outcomes Research, which conducts outcomes-based research on rehabilitation technologies such as prostheses, orthoses, rehabilitation robotics and other adaptive technologies. In addition to his work at Shirley Ryan AbilityLab, he is Professor of Physical Medicine, Rehabilitation, Medical Social Sciences, and Physical Therapy and Human Movement Sciences at the Northwestern University Feinberg School of Medicine. Dr. Jayaraman's work has been published in more than 100 peer-reviewed journal articles, and has been funded by myriad leading organizations, including the U.S. Department of Defense, the National Institutes of Health, the National Science Foundation and the Michael J. Fox Foundation. He also holds various external leadership positions, serving as Director of Global Outreach for the Wearable Robotics Association and editorial Board Member for the International Journal of Stroke. Dr. Jayaraman also is involved with the American Orthotic Prosthetic Association, the Society for Neuroscience and the American Physical Therapy Association. Dr. Jayaraman holds a BS in Physical Therapy from SRM Medical College Hospital and Research Centre in Chennai, India; an MS in Physical Therapy from Georgia State University; and a PhD in Rehabilitation Medicine from the University of Florida in Gainesville. Show Mentions and Resources: https://www.world-stroke.org https://brainqtech.com/ https://wolkairbag.com/ https://research.samsung.com/robot#teaser-video https://rewalk.com/restore-exo-suit/ https://www.bbc.com/news/science-environment-43146117 https://www.sralab.org/researchers/arun-jayaraman-pt-phd https://www.sralab.org/services/international-patients Show Credits: Music intro credit to Jake Dansereau, connect at JAKEEZo on Soundcloud @user-257386777. Our intro welcome is the voice of Caroline Goggin, a stroke survivor and our first podcast guest! Please listen to her inspiring story on Episode 2 of the podcast. Thank you Caroline! Our Show is Now on the Health Podcast Network! https://healthpodcastnetwork.com/show/the-know-stroke-podcast/ Until next time, be sure to give the show a like and share, +follow and connect with us on social or contact us to be a guest on the Know Stroke Podcast. Connect with Us and Share our Show on Social: Web Twitter Facebook  Instagram Youtube Linkedin

Arjun Jayaraman, portfolio manager at Causeway Capital Management says that emerging markets investors are trying to decide if the next 10 years will be as flat and troubled as the last decade, and he says that despite prominent, key headline risks, China and emerging markets have plenty of promise now, and should turn out to be better over the next 10 years than they were over the last 10. Jayaraman says if forced to invest in just one emerging market country, his pick would be South Korea, but he thinks that China and others are well-positioned to make progress once the global inflation crisis eases. Daniel Strachman, managing partner at A&C Advisors and the author of "Julian Robertson: A Tiger in the Land of Bulls and Bears," discusses the legendary hedge fund manager and what made him one of the most influential and unique forces ever in money management; Robertson passed away Tuesday at age 90. Ted Rossman, senior industry analyst at  CreditCards.com; @tedrossman; @creditcardscom

The power structure in Maharashtra has seen a major shift in the last week. Eknath Shinde is now the new Chief Minister of Maharashtra, replacing Uddhav Thackeray, who resigned after a weeklong drama. To break down this intense scenario, we have our resident expert Rohit Jayaraman. In this deep dive, he spoke about topics such as a summary of recent events, reasons for fissure in the Shiv Sena, the role of each of the players in the drama, and more. 

Mahesh Jayaraman is Co-Founder of www.sepalika.com, a wholly online clinic focussed on women's hormone health, especially on infertility issues. Sepalika has treated nearly a thousand women to date. A journalist for the first half of his career, Mahesh was forced to study nutrition and lifestyle medicine when his wife faced a life-threatening condition. He then spent the next two decades qualifying himself in acupressure, nutrition, reflexology, EFT and NLP, and Bach Flower Remedies. He is a Master of Functional Blood Chemistry Analysis from the Optimal Dx Academy, USA and is a certified Functional Hormone Specialist from Functional Women's Academy, USA. How is poor sleep impactful on women and fertility? What is the right test to know if your fertility is affected by poor sleep? How is poor sleep impactful on men and fertility? How is poor sleep a mediator in fertility outcomes? How can you use a baby's technique to release stress? What is Sepalika's five petal program to improve egg quality for fertility success? For more on Mahesh Jayaraman you can follow him: Website: www.sepalika.com   Facebook:  https://www.facebook.com/sepalikahealth  Instagram: https://www.instagram.com/sepalikafertility/  Linked In: www.linkedin.com/in/maheshjayaraman  Related Episodes: 103 - Detoxification, Women's Hormones & Sleep With Dr Wendie Trubow  117-Guided Sleep Meditation-Soothing Sacred Feminine  014 - Hormone Deficiency & Bio-identical Hormones  004 - Women's Hormones and Sleep with Jessica Drummond  -For more on Deepa: Deepa is an Allied Functional Medicine Practitioner, Author and a Yogini at Phytothrive. Having a son with a rare adrenal disorder gave her insight into the working of the adrenals. Her articles have been shared by Dr Mark Hyman, MD, a 14 times NY Times Bestselling Author. She also gave the opening speech on Health Hacks at Amazon Web Services & YourStory HeathTech 2019 to heads of healthcare start-ups in India. She is in the YourStory100 Digital Influencers Of 2020. Her book on sleep with HarperCollins releases in 2022. She has been featured on the award winning podcast 15-Minute Matrix and UK Health Radio discussing sleep.

Investment in behavioral health companies has exploded in recent years, with a notable uptick in private equity activity since the beginning of the pandemic. PE firms closed over 70 buyouts in behavioral health in 2020, more than double 2016's number, according to PitchBook data.In this episode, PitchBook PE and healthcare senior analyst Rebecca Springer welcomes Avi Jayaraman and Dexter Braff for a discussion about the rapidly evolving behavioral health industry and how private equity is helping to drive innovation in the space. Jayaraman co-founded Sonara, which provides a remote solution for medication-assisted opioid addiction treatment. Braff is president of The Braff Group, an M&A advisory firm specializing in healthcare. They share their thoughts on growth and greenfield opportunities in behavioral health, the advantages and challenges that PE firms face when operating in healthcare, how technology can bridge staffing shortages and more. Plus, PitchBook senior manager of publishing joins discuss the 2021 Annual Interactive PE Lending League Tables and PitchBook's exclusive coverage of venture debt deal terms. In the Upwork segment of "Innovations in Private Equity," Tim Sanders is joined by Dave Stangis, chief sustainability officer and partner at Apollo Global Management. Dave discusses how private equity firms can bring strong sustainability practices to life internally as well as across the portfolio companies they're invested in.Listen to all of Season 5, presented by Upwork, and subscribe to get future episodes of "In Visible Capital" on Apple Podcasts, Spotify, Google Podcasts or wherever you listen. For inquiries, please contact us at podcast@pitchbook.com.

In this episode, Shiv is in conversation with Anjali, a 11 year old girl, who has been into coding since she was 7. Anjali shares:Her interest in horses and dogs, and other interestsHow she got into codingCalling herself an introvert, but enjoying competitionUsing logic to interact with animalsWhat she likes and doesn't like about codingCreating a tic-tac-toe to play with an AI opponentAbout writing programs alone or with others sometimesHow she comes up with ideas when entering a competitionWhere programming can be appliedHow she finds time to program.. Do not miss it!How she influenced a friend to learn codingThe pranks she and her friend play during online classesWhat she would love to be known for : making a robot that passes the turing testHer experience with using big computersHow she gets into a calm state of mind - to write programs or even in other situationsHow to get a 5 year old to start codingIf there is a difference between boys and girls on how they learn codingOn programming as a class subject and as a hobbyHer message for older women in ITAnjali Jayaraman is in Grade 7 and lives in Chennai. She loves horse riding and puppies. She is good at debating. Besides coding, her favourite activity is to create worlds in Minecraft and play video games.Her project ‘Toothzy' was chosen for 'Best Design/UI' in the 2021 California AI + Healthcare Summit Ideathon competition. https://www.girlscomputingleague.org/Link to the project: https://youtu.be/xxwI36-weJs Certificate https://drive.google.com/file/d/1LBiLp47trP28jvIfuv_c3Jwlj3nERAQY/view?usp=drivesdkShe got a $700 scholarship for ‘Introduction to Quantum Computing for High school Students' https://www.qubitbyqubit.org/Her idol is Warren Buffet and she wants to be either an entrepreneur or an Investor in technology business when she grows up.Her other projects: https://youtu.be/UlcywVyvWxM Teaching AI to Shakespeare: To AI or not to AI

These days every organisation wants its teams to be more entrepreneurial and innovative. From holacracy to skunk-works and MBO to self-managing teams, a wide range of approaches have been tested over time. Yet what are the key variables that drive greater performance in entrepreneurial teams? In a recent paper published in the journal Organization Science, Professor Linus Dahlander and colleagues explored the way that entrepreneurial teams are organised and structured. By looking at two key variables – autonomy over who to work with or what to work on – Dahlander and colleagues identified some key approaches that leaders and organisations can use to help their teams be more creative and innovative. Linus Dahlander is a professor at the European School of Management and Technology - ESMT Berlin, Director of Research, and the holder of the Lufthansa Group Chair in Innovation. He received his PhD in from Chalmers University of Technology and undertook post doctoral studies at Stanford University. He was previously an assistant professor and an Advanced Institute of Management Research Fellow with the Innovation and Entrepreneurship Group at Imperial College Business School. Linus teaches in the areas of innovation, entrepreneurship, and networks, and is also a consultant and advisor to startups, large multinationals as well as government organizations on issues around innovation and networks. In 2017, Linus was recognized as one of the Best 40 Under 40 Professors by Poets & Quants. In his ongoing research Linus investigates how new ideas and innovations are developed in networks and communities. The ongoing projects use large-scale analysis of networks, which he integrates with a deeper appreciation for what content flows through networks. Linus seeks to study novel questions which can advance the academic literature, and which at the same time focus on issues that can affect how managers think about their business to help them make better decisions. Linus' research has been published in the Academy of Management Journal, Administrative Science Quarterly, Organization Science, Research Policy, and Strategic Management Journal among others. He served as an Associate Editor for the Academy of Management Journal in the 2013-2016 editorial team. The articles discussed in the interview can be accessed here: https://pubsonline.informs.org/doi/full/10.1287/orsc.2021.1520 (Boss, V., Dahlander, L., Ihl, C., & Jayaraman, R. (2021). Organizing Entrepreneurial Teams: A Field Experiment on Autonomy over Choosing Teams and Ideas. Organization Science.) https://hbr.org/2021/12/when-autonomy-helps-team-performance-and-when-it-doesnt

Rohit Jayaraman is a corporate lawyer who has also worked as a political consultant.

I❤️ARR Podcast with Rohith Jayaraman In this video, I had the honour of having the amazingly talented Rohith. We spoke about his journey, Berklee College and also his opportunity to do backing vocals in during ARR Live in the US. We deep dived into various aspects of Music and his journey. This is a must watch for sure.

Kishore Jayaraman is the President of Rolls-Royce for India and South Asia. He describes Outcomes Focused Leadership as our internal satellite navigation system where we understand where we are coming from and where we are going as a leader. Kishore's leadership has been tested during the recent pandemic and his Outcomes Focused Leadership has allowed him to create and communicate a clear vision with meaning and to build relevant milestones and metrics to measure progress all wrapped in a sense of urgency and psychological safety. Kishore will also share his three point plan during this episode which you can put into practice today! 

Hello Soft Matter Enthusiasts! Welcome to another episode of The Soft Matter Show. Our today's guest is Dr. Arthi Jayaraman (https://cbe.udel.edu/people/faculty/arthij/). Arthi is a Professor with joint appointments at the department of chemical and biomolecular engineering (https://cbe.udel.edu/) and the department of material science and engineering (https://mseg.udel.edu/) at The University of Delaware. Arthi is a skilled multi-tasker and manages to be on the editorial board of multiple prestigious journals and organizes outreach events while being a full-time professor. In this episode, Arthi shared her journey from being a student to a professor. In addition to the fabulous simulations Arthi's team is creating at Delaware, I was stunned at the research philosophy Arthi has cultivated. Arthi also shared her responsibilities as an editorial board member and how she manages her time. This episode I believe is a fantastic combination of life and philosophy of research, I hope all of you enjoy this! Read more: Dr. Arthi Jayaraman http://udel.edu/~arthij/ E-mail: arthij@udel.edu Amal Narayanan https://www.thesoftmattershow.com E-mail: amalnarayanan@thesoftmattershow.com

Full Notation / Meanings -> http://www.shivkumar.org/music/#d Ragam: Revathi (2nd Melakartha (Ratnangi) Janyam) https://en.wikipedia.org/wiki/Revati_(raga) ARO: S R₁ M₁ P N₂ Ṡ || AVA: Ṡ N₂ P M₁ R₁ S || Talam: Misra Chapu Composer: Lalgudi Jayaraman Pallavi: dhIm dhIm tanananana dhIm dhiM tananana dhIm dhIm dhIm nAdru dhIm tomdru dhIm tana jhaNuta dhIm tanata dhIm tata NatOm tOm tOm tAm tAm tAm dhIm dhIm Anupallavi: tAkiTatOm dhIm takiTatOm dhIkiTa jham dhIm takiTa jham tataratAni dhIm taratAni dhIm tatAni dhIm tatAni dhImta Charanam: kOla muruganaik-kANa eNNi kAlamellAm kAttirundEn vElanO enai EnO marandAn jAlamO en kAlamO ariyEn tAm tAm ta dhIm dhIm ta tajham takiTajham ni sa* pa ni ma pa ri ma sa ri *ni tatAm tadhIm tajham taNam ma* ma* , ri* ma* ma* ri* ri* ni ni ma mA rI takajhaNU takajhaNu takajhaNu dhIm taLAngu takajhaNu dhIm taLAngu takajhaNu dhIm taLAngu takajhaNu dhIm tattit taLangu takajhaNU dhIm tattit talAngu takajhaNu dhIm tattit taLAngu takajhaNu Meaning of the charana sahityam: (Courtesy: https://sapthaswaras.blogspot.com/2009/02/thillana-in-revati-raaga.html ) I have been waiting (kAttirundEn) all my life (kAlam ellAm) just to behold (kANa) the beautiful/handsome (kOla) murugan, but I am not sure (EnO) if it is artful pretence (jAlamO) on his part, or the consequence of my own karmA (kAlamO) that has made the spear-weilding Lord (vElanO) to have forgotten (marandAn) me (enai).